Biosenors taps Wang as new COO
Biosensors International Group has appointed Jack Wang, MD, as chief operating officer (COO).
Wang has been involved in Biosensors’ operating activities and product development efforts since 2001, most recently serving as the CEO of JW Medical Systems (JWMS), its China-based joint venture with Shandong Weigao Group Medical Polymer, according to the Singapore-based company.
Wang will remain as the senior officer of JWMS and will assume responsibility for all operating activities of Biosensors, including manufacturing, quality and product development, Biosensors said.
Prior to joining Biosensors in 2001, the company said Wang served as manager of new product development for Johnson & Johnson (Cordis) and as project group leader of stent delivery systems for Guidant
Wang has been involved in Biosensors’ operating activities and product development efforts since 2001, most recently serving as the CEO of JW Medical Systems (JWMS), its China-based joint venture with Shandong Weigao Group Medical Polymer, according to the Singapore-based company.
Wang will remain as the senior officer of JWMS and will assume responsibility for all operating activities of Biosensors, including manufacturing, quality and product development, Biosensors said.
Prior to joining Biosensors in 2001, the company said Wang served as manager of new product development for Johnson & Johnson (Cordis) and as project group leader of stent delivery systems for Guidant